Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/10/2025

Ceftriaxone Use in Pregnancy

Safety and Efficacy

  • The Centers for Disease Control and Prevention (CDC) states that data are insufficient to recommend ceftriaxone for treatment of maternal infection and prevention of congenital syphilis 1
  • The CDC recommends that penicillin remains the only proven effective treatment for preventing maternal transmission to the fetus and treating fetal syphilis infection 2, 3
  • Pregnant women with penicillin allergy should undergo desensitization and receive penicillin rather than alternative agents, as recommended by the CDC 1, 2, 4, 5

Clinical Considerations

  • There is a potential risk of cross-reactivity with penicillin allergy, although the risk is generally low, according to the CDC 6
  • For neurosyphilis in HIV-infected pregnant patients, some specialists suggest ceftriaxone 1-2g IV daily for 10-14 days, but this remains based on limited observational data, as reported by the CDC 3